1
|
Kerkhofs TM, Verhoeven RH, Van der Zwan
JM, et al: Adrenocortical carcinoma: a population-based study on
incidence and survival in the Netherlands since 1993. Eur J Cancer.
49:2579–2586. 2013. View Article : Google Scholar : PubMed/NCBI
|
2
|
McAteer JP, Huaco JA and Gow KW:
Predictors of survival in pediatric adrenocortical carcinoma: a
Surveillance, Epidemiology, and End Results (SEER) program study. J
Pediatr Surg. 48:1025–1031. 2013. View Article : Google Scholar : PubMed/NCBI
|
3
|
Redlich A, Boxberger N, Strugala D, et al:
Systemic treatment of adrenocortical carcinoma in children: data
from the German GPOH-MET 97 trial. Klin Padiatr. 224:366–371. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Michalkiewicz E, Sandrini R, Figueiredo B,
et al: Clinical and outcome characteristics of children with
adrenocortical tumors: a report from the International Pediatric
Adrenocortical Tumor Registry. J Clin Oncol. 22:838–845. 2004.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Sabbaga CC, Avilla SG, Schulz C, Garbers
JC and Blucher D: Adrenocortical carcinoma in children: clinical
aspects and prognosis. J Pediatr Surg. 28:841–843. 1993. View Article : Google Scholar : PubMed/NCBI
|
6
|
Ciftci AO, Senocak ME, Tanyel FC and
Büyükpamukçu N: Adrenocortical tumors in children. J Pediatr Surg.
36:549–554. 2001. View Article : Google Scholar : PubMed/NCBI
|
7
|
Dehner LP and Hill DA: Adrenal cortical
neoplasms in children: why so many carcinomas and yet so many
survivors? Pediatr Dev Pathol. 12:284–291. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wieneke JA, Thompson LD and Heffess CS:
Adrenal cortical neoplasms in the pediatric population: a
clinicopathologic and immunophenotypic analysis of 83 patients. Am
J Surg Pathol. 27:867–881. 2003. View Article : Google Scholar : PubMed/NCBI
|
9
|
Weiss LM: Comparative histologic study of
43 metastasizing and nonmetastasizing adrenocortical tumors. Am J
Surg Pathol. 8:163–169. 1984. View Article : Google Scholar : PubMed/NCBI
|
10
|
van Slooten H, Schaberg A, Smeenk D and
Moolenaar AJ: Morphologic characteristics of benign and malignant
adrenocortical tumors. Cancer. 55:766–773. 1985.PubMed/NCBI
|
11
|
Hubertus J, Boxberger N, Redlich A, von
Schweinitz D and Vorwerk P: Surgical aspects in the treatment of
adrenocortical carcinomas in children: data of the GPOH-MET 97
trial. Klin Padiatr. 224:143–147. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Doll R and Cook P: Summarizing indices for
comparison of cancer incidence data. Int J Cancer. 2:269–279. 1967.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Casparie M, Tiebosch AT, Burger G,
Blauwgeers H, van de Pol A, van Krieken JH and Meijer GA: Pathology
databanking and biobanking in The Netherlands, a central role for
PALGA, the nationwide histopathology and cytopathology data network
and archive. Cell Oncol. 29:19–24. 2007.PubMed/NCBI
|
14
|
Weiss LM, Medeiros LJ and Vickery AL Jr:
Pathologic features of prognostic significance in adrenocortical
carcinoma. Am J Surg Pathol. 13:202–206. 1989. View Article : Google Scholar : PubMed/NCBI
|
15
|
Fassnacht M, Terzolo M, Allolio B, et al:
Combination chemotherapy in advanced adrenocortical carcinoma. N
Engl J Med. 366:2189–2197. 2012. View Article : Google Scholar
|
16
|
Faria AM and Almeida MQ: Differences in
the molecular mechanisms of adrenocortical tumorigenesis between
children and adults. Mol Cell Endocrinol. 351:52–57. 2012.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Fassnacht M, Kroiss M and Allolio B:
Update in adrenocortical carcinoma. J Clin Endocrinol Metab.
98:4551–4564. 2013. View Article : Google Scholar : PubMed/NCBI
|
18
|
Fassnacht M and Allolio B: Clinical
management of adrenocortical carcinoma. Best Pract Res Clin
Endocrinol Metab. 23:273–289. 2009. View Article : Google Scholar
|
19
|
Boechat GA, Stinghen ST, Custódio G, et
al: Placental alkaline phosphatase in pediatric adrenocortical
cancer. J Pediatr Hematol Oncol. 33:e149–e153. 2011. View Article : Google Scholar : PubMed/NCBI
|
20
|
Wilkin F, Gagné N, Paquette J, Oligny LL
and Deal C: Pediatric adrenocortical tumors: molecular events
leading to insulin-like growth factor II gene overexpression. J
Clin Endocrinol Metab. 85:2048–2056. 2000.PubMed/NCBI
|
21
|
Mastellaro MJ, Seindinger AL, Yunes JA, et
al: Adrenocortical tumors in children: analysis of 105 patients
from a single institution. In: The Fourth International Symposium
on Adrenal Cancer; Paris. Abst. 2013
|
22
|
Libe R, Borget I, Ronchi C, Terzolo M,
Haaf M, Laino F, et al: Prognostic factors of advanced unresectable
by stage III and IV ENS@T adrenocortical carcinomas (ACC). In: The
15th European Congress of Endocrinology; Copenhagen. 2013; abstract
Endocrine Abst 32 OC4.3. View Article : Google Scholar : 2013
|
23
|
Terzolo M, Angeli A, Fassnacht M, et al:
Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J
Med. 356:2372–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
24
|
Terzolo M, Baudin E, Ardito A, et al:
Mitotane levels predict the outcome of patients with adrenocortical
carcinoma treated adjuvantly following radical resection. Eur J
Endocrinol. 169:263–270. 2013. View Article : Google Scholar
|
25
|
Sandrini R, Ribeiro RC and DeLacerda L:
Childhood adrenocortical tumors. J Clin Endocrinol Metab.
82:2027–2031. 1997.PubMed/NCBI
|
26
|
Borges KS, Moreno DA, Martinelli CE Jr, et
al: Spindle assembly checkpoint gene expression in childhood
adrenocortical tumors (ACT): overexpression of Aurora kinases A and
B is associated with a poor prognosis. Pediatr Blood Cancer.
60:1809–1816. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Sbragia L, Oliveira-Filho AG, Vassallo J,
Pinto GA, Guerra-Junior G and Bustorff-Silva J: Adrenocortical
tumors in Brazilian children: immunohistochemical markers and
prognostic factors. Arch Pathol Lab Med. 129:1127–1131.
2005.PubMed/NCBI
|
28
|
Ribeiro RC, Sandrini Neto RS, Schell MJ,
Lacerda L, Sambaio GA and Cat I: adrenocortical carcinoma in
children: a study of 40 cases. J Clin Oncol. 8:67–74.
1990.PubMed/NCBI
|
29
|
Klein JD, Turner CG, Gray FL, et al:
Adrenal cortical tumors in children: factors associated with poor
outcome. J Pediatr Surg. 46:1201–1207. 2011. View Article : Google Scholar : PubMed/NCBI
|
30
|
Ribeiro RC, Sandrini F, Figueiredo B, et
al: An inherited p53 mutation that contributes in a
tissue-specific manner to pediatric adrenal cortical carcinoma.
Proc Natl Acad Sci USA. 98:9330–9335. 2001.PubMed/NCBI
|
31
|
Orhan D, Kale G, Cağlar M, Göğüş S and
Karaağaoğlu E: Histone mRNA in situ hybridization and Ki 67
immunohistochemistry in pediatric adrenocortical tumors. Virchows
Arch. 448:591–596. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
West AN, Neale GA, Pounds S, et al: Gene
expression profiling of childhood adrenocortical tumors. Cancer
Res. 67:600–608. 2007. View Article : Google Scholar : PubMed/NCBI
|
33
|
Martins AC, Cologna AJ, Tucci S Jr, Suaid
HJ and Falconi RA: Clinical features and immunoexpression of p53,
MIB-1 and proliferating cell nuclear antigen in adrenal neoplasms.
J Urol. 173:2138–2142. 2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
Hanna AM, Pham TH, Askegard-Giesmann JR,
Grams JM, Iqbal CW, Stavlo P and Moir CR: Outcome of adrenocortical
tumors in children. J Pediatr Surg. 43:843–849. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Chen QL, Su Z, Li YH, Ma HM, Chen HS and
Du ML: Clinical characteristics of adrenocortical tumors in
children. J Pediatr Endocrinol Metab. 24:535–541. 2011.PubMed/NCBI
|
36
|
Cagle PT, Hough AJ, Pysher TJ, et al:
Comparison of adrenal cortical tumors in children and adults.
Cancer. 57:2235–2237. 1986. View Article : Google Scholar : PubMed/NCBI
|
37
|
Zancanella P, Pianovski MA, Oliveira BH,
et al: Mitotane associated with cisplatin, etoposide, and
doxorubicin in advanced childhood adrenocortical carcinoma:
mitotane monitoring and tumor regression. J Pediatr Hematol Oncol.
28:513–524. 2006. View Article : Google Scholar
|
38
|
Narasimhan KL, Samujh R, Bhansali A,
Marwaha RK, Chowdhary SK, Radotra BD and Rao KL: Adrenocortical
tumors in childhood. Pediatr Surg Int. 19:432–435. 2003. View Article : Google Scholar : PubMed/NCBI
|
39
|
Stewart JN, Flageole H and Kavan P: A
surgical approach to adrenocortical tumors in children: the
mainstay of treatment. J Pediatr Surg. 39:759–763. 2004. View Article : Google Scholar : PubMed/NCBI
|
40
|
Magro G, Esposito G, Cecchetto G, et al:
Pediatric adrenocortical tumors: morphological diagnostic criteria
and immunohistochemical expression of matrix metalloproteinase type
2 and human leucocyte-associated antigen (HLA) class II antigens.
Results from the Italian Pediatric Rare Tumor (TREP) Study project.
Hum Pathol. 43:31–39. 2012.
|
41
|
McDonnell CM and Zacharin MR: Adrenal
cortical tumours: 25 years’ experience at the Royal Children’s
Hospital, Melbourne. J Paediatr Child Health. 39:682–685. 2003.
|
42
|
Ahmed AA: Adrenocortical neoplasms in
young children: age as a prognostic factor. Ann Clin Lab Sci.
39:277–282. 2009.PubMed/NCBI
|
43
|
Cho MJ, Kim DY, Kim SC, Kim TH and Kim IK:
Adrenocortical tumors in children 18 years old and younger. J
Korean Surg Soc. 82:246–250. 2012.PubMed/NCBI
|
44
|
Pusantisampan T, Sangkhathat S, Kayasut K,
Kanngurn S, Jaruratanasirikul S, Chotsampancharoen T and
Kritsaneepaiboon S: Cushing’s syndrome in an infant secondary to
malignant adrenocortical tumors with somatic mutation of
beta-catenin. Pediatr Dev Pathol. 13:238–242. 2010.
|
45
|
de Lima LO, Lerario AM, Alencar GA, et al:
Clinical and molecular aspects of a pediatric metachronous
adrenocortical tumor. Arq Bras Endocrinol Metabol. 55:72–77.
2011.PubMed/NCBI
|
46
|
Aricò M, Bossi G, Livieri C, Raiteri E and
Severi F: Partial response after intensive chemotherapy for adrenal
cortical carcinoma in a child. Med Pediatr Oncol. 20:246–248.
1992.PubMed/NCBI
|
47
|
Delaney HM, Prauner RD and Person DA:
Germline p53 mutation in a Micronesian child with adrenocortical
carcinoma and subsequent osteosarcoma. J Pediatr Hematol Oncol.
30:803–806. 2008. View Article : Google Scholar : PubMed/NCBI
|
48
|
De León DD, Lange BJ, Walterhouse D and
Moshang T: Long-term (15 years) outcome in an infant with
metastatic adrenocortical carcinoma. J Clin Endocrinol Metab.
87:4452–4456. 2002.PubMed/NCBI
|
49
|
Fiszer-Maliszewska L, Kazanowska B and
Padzik J; Regional Blood Transfusion Center. p53 Tetramerization
domain mutations: germline R342X and R342P, and somatic R337G
identified in pediatric patients with Li-Fraumeni syndrome and a
child with adrenocortical carcinoma. Fam Cancer. 8:541–546. 2009.
View Article : Google Scholar
|
50
|
Fudge EB, von Allmen D, Volmar KE and
Calikoglu AS: Cushing syndrome in a 6-month-old infant due to
adrenocortical tumor. Int J Pediatr Endocrinol. 2009:1687492009.
View Article : Google Scholar : PubMed/NCBI
|
51
|
Ghazizadeh F, Ebadi M, Alavi S, Arzanian
M, Shamsian B and Jadali F: Adrenocortical carcinoma presenting
with heterosexual pseudoprecocious puberty shortly after birth:
case report and review. Ecancermedicalscience. 7:2892013.PubMed/NCBI
|
52
|
Godil MA, Atlas MP, Parker RI, et al:
Metastatic congenital adrenocortical carcinoma: a case report with
tumor remission at 3 1/2 years. J Clin Endocrinol Metab.
85:3964–3967. 2000.PubMed/NCBI
|
53
|
Hah JO: Intensive chemotherapy with
autologous PBSCT for advanced adrenocortical carcinoma in a child.
J Pediatr Hematol Oncol. 30:332–334. 2008. View Article : Google Scholar : PubMed/NCBI
|
54
|
Hara F, Kishikawa T, Tomishige H,
Nishikawa O, Nishida Y and Kongo M: A child with adrenocortical
carcinoma who underwent percutaneous ethanol injection therapy for
liver metastasis. J Pediatr Surg. 38:1237–1240. 2003. View Article : Google Scholar : PubMed/NCBI
|
55
|
Inage E, Saito M, Saito Y, Takata O,
Fujimura J, Yamataka A and Shimizu T: Contralateral pleural
recurrence of adrenocortical carcinoma after surgical resection.
Pediatr Int. 53:600–603. 2011. View Article : Google Scholar : PubMed/NCBI
|
56
|
Kanmaz T, Demirbilek S, Ozardali I, Safali
M, Guran S and Yucesan S: Nonfunctioning adrenocortical carcinoma
in a child. Pediatr Pathol Mol Med. 22:405–410. 2003. View Article : Google Scholar
|
57
|
Khayat CM and Johnston DL:
Rhabdomyosarcoma, osteosarcoma, and adrenocortical carcinoma in a
child with a germline p53 mutation. Pediatr Blood Cancer.
43:683–686. 2004. View Article : Google Scholar : PubMed/NCBI
|
58
|
Ko JH, Lee HS, Hong J and Hwang JS:
Virilizing adrenocortical carcinoma in a child with Turner syndrome
and somatic TP53 gene mutation. Eur J Pediatr. 169:501–504. 2010.
View Article : Google Scholar : PubMed/NCBI
|
59
|
Lin MT, Shieh JJ, Chang JH, Chang SW, Chen
TC and Hsu WH: Early detection of adrenocortical carcinoma in a
child with Li-Fraumeni syndrome. Pediatr Blood Cancer. 52:541–544.
2009. View Article : Google Scholar : PubMed/NCBI
|
60
|
Mertens F, Kullendorff CM, Moell C,
Alumets J and Mandahl N: Complex karyotype in a childhood
adrenocortical carcinoma. Cancer Genet Cytogenet. 105:190–192.
1998. View Article : Google Scholar : PubMed/NCBI
|
61
|
Miyoshi Y, Oue T, Oowari M, et al: A case
of pediatric virilizing adrenocortical tumor resulting in
hypothalamic-pituitary activation and central precocious puberty
following surgical removal. Endocr J. 56:975–982. 2009. View Article : Google Scholar
|
62
|
Pivnick EK, Furman WL, Velagaleti GV,
Jenkins JJ, Chase NA and Ribeiro RC: Simultaneous adrenocortical
carcinoma and ganglioneuroblastoma in a child with Turner syndrome
and germline p53 mutation. J Med Genet. 35:328–332. 1998.
View Article : Google Scholar : PubMed/NCBI
|
63
|
Romaguera RL, Minagar A, Bruce JH, et al:
Adrenocortical carcinoma with cerebral metastasis in a child: case
report and review of the literature. Clin Neurol Neurosurg.
103:46–50. 2001. View Article : Google Scholar : PubMed/NCBI
|
64
|
Sorgo W, Meyer D, Rodens K, Homoki J,
Heinze E, Heymer B and Siebenmann R: Testosterone-secreting
adrenocortical tumor in a pubertal girl. Case report and review of
the literature. Horm Res. 30:217–223. 1988. View Article : Google Scholar : PubMed/NCBI
|
65
|
Wagner AS, Fleitz JM and
Kleinschmidt-Demasters BK: Pediatric adrenal cortical carcinoma:
brain metastases and relationship to NF-1, case reports and review
of the literature. J Neurooncol. 75:127–133. 2005. View Article : Google Scholar : PubMed/NCBI
|
66
|
Wong LM, Li CH, Chan OK, Shek CC and Kwong
NS: A 12-year-old Chinese girl with Cushing syndrome and
virilization due to adrenocortical carcinoma. J Pediatr Endocrinol
Metab. 24:193–196. 2011.PubMed/NCBI
|